Jose Reyes batting third? Does it matter?

0 Comments

Earlier Matthew asked whether Jerry Manuel’s idea to bat Jose Reyes third is a good idea.  Here’s a second question: Would it make a difference? 

It probably won’t. There have been multiple studies of lineup optimization over the years. For the most part they conclude that the particular lineup doesn’t make a whole hell of a lot of difference. Oh sure, on average the guys near the bottom of the order will get fewer plate appearances than the guys at the top, but as long as you group your better hitters near the top and your worse ones near the bottom, the specific slots don’t much matter.

The upshot: as long as Manuel has Reyes, Beltran, Wright and Bay up near the top it probably doesn’t matter who’s third. The only thing that could change this is something Manuel himself pointed out, and that’s that it might be a bad idea if such a move gives Reyes the heebie jeebies. And like I said this morning, the manager’s primary job is to keep things on an even keel.

So feel free to mess around Jerry. The papers will squawk some, but they’re going to do that no matter what you do, so you may as well do what you want to do.  

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.